Optibiotix Health (OPTI)


Latest News

OptiBiotix Health launches LPLDL,SlimBiome products

OptiBiotix Health has announced the successful launch of its SlimBiome and LPLDL products. "We are extremely pleased ...

Successful launch of LPLDL and SlimBiome products

RNS Number: 1779F OptiBiotix Health PLC 16 May 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") Successful Launch of LP LDL and SlimBiome products at Vitafoods 2017 OptiB i ot i x H ealth p l c (A I M :O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, and d ia b ete s a nn o un ces the su...

OptiBiotix notes non-exclusive European licence deal

OptiBiotix Health has agreed to grant a non-exclusive license agreement to Nutrilinea for the production and commercialis...

LPLDL? Non-Exclusive European License Agreement

RNS Number: 5111E OptiBiotix Health PLC 09 May 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") LP LDL Non-Exclusive European License Agreement OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, a nn o un ces that it has agree...

All News

16-05-17OptiBiotix Health launches LPLDL,SlimBiome productsStockMarketWire
16-05-17Successful launch of LPLDL and SlimBiome productsRNS
09-05-17OptiBiotix notes non-exclusive European licence dealStockMarketWire
09-05-17LPLDL? Non-Exclusive European License AgreementRNS
03-05-17Presentation of abstract at conferenceRNS
25-04-17Optibiotix discusses 'critical' couple of yearsInteractive Investor
25-04-17Optibiotix Health notes first German sales of LPLDLStockMarketWire
25-04-17First German salesRNS
25-04-17OptiBiotix Health marginally widens FY pretax lossStockMarketWire
25-04-17Final ResultsRNS
04-04-17Notice of ResultsRNS
29-03-17UK Investor Show attendanceRNS
24-03-17Holding(s) in CompanyRNS
21-03-17Intention to float SkinBiotherapeuticsRNS
15-03-17Confirmation of Director appointments to the BoardRNS
08-03-17OptiBiotix Health in European agreement with Sacco SrlStockMarketWire
08-03-17European agreement with Sacco SrlRNS
01-03-17Launch of products at Vitafoods 2017RNS
08-02-17Exercise of Warrants and Issue of EquityRNS
26-01-17Result of General MeetingRNS
24-01-17Presentation of research dataRNS
18-01-17OptiBiotix appoints sales and marketing directorStockMarketWire
18-01-17Appointment of Sales and Marketing DirectorRNS
17-01-17Holding(s) in CompanyRNS
13-01-17OptiBiotix options exercised StockMarketWire
13-01-17Exercise of Option and Issue of EquityRNS
12-01-17Presentation of research data at ProBiota 2017RNS
11-01-17OptiBiotix Health warrants exercised StockMarketWire
11-01-17Exercise of Warrants and Issue of EquityRNS
05-01-17OptiBiotix Health appoints Commercial DirectorStockMarketWire
05-01-17Appointment of Commercial DirectorRNS
03-01-17OptiBiotix Health notes increased investment in THWLCStockMarketWire
03-01-17Increased investment in THWLCRNS
23-12-16Notice of General Meeting of Warrant HoldersRNS
13-12-16OptiBiotix in joint development deal with multinationalStockMarketWire
13-12-16Joint Product Agreement with multinationalRNS
01-12-16Exercise of Warrants and Issue of EquityRNS
29-11-16Scientific and Commercial UpdateRNS
03-11-16Presentation of data at European Microbiome SummitRNS
26-10-16OptiBiotix provides scientific, commerical updateStockMarketWire

RSS feeds

  • Editorial news feed for LSE:OPTI Editorial
  • Regulatory news feed for LSE:OPTI Regulatory